Commentary

How a new CNS company was founded, then sold

Read more

J.P. Morgan goes virtual

Read more

The next direction for Alzheimer's disease treatments

Read more

Live biotherapeutics change the pharma landscape

Read more

Hot targets in immuno-oncology

Read more

Insect-derived peptides - next generation antibiotics?

Read more

Phosphatases rise from the ashes

Read more

The data-driven autobahn to cures

Read more

Why we should take a second look at RNA therapeutics

Read more

Forbion to create and grow biotech companies

Read more